Intercept Announces Updated U.S. Prescribing Information for Ocaliva® (obeticholic acid) to Reinforce Appropriate Dosing in PBC Patients with Advanced Cirrhosis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Intercept Announces Updated U.S. Prescribing Information for Ocaliva® (obeticholic acid) to Reinforce Appropriate Dosing in PBC Patients with Advanced Cirrhosis

Intercept (ICPT): In this Case, the Black Box Warning is a Positive - Baird

February 1, 2018 10:13 AM EST

Baird analyst Brian Skorney said the Black Box warning on Intercept Pharmaceuticals' (NASDAQ: ICPT) Ocaliva is a positive. The firm maintained an Outperform rating and price target of $253.00

Skorney commented, "While black boxed warnings are generally not a good thing, the... More